Cargando…
Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
BACKGROUND: Cisplatin‐based chemotherapy is a therapeutic strategy against non‐small cell lung cancer (NSCLC). However, cancers relapse after chemotherapy due to a dormant state of residual cancer cells. Extracellular vesicles and particles (EVPs) are active carriers of proteins and nucleic acid. He...
Autores principales: | Xu, Jiaqi, Wang, Lujuan, Yin, Na, Chen, Anqi, Yi, Junqi, Tang, Jingqun, Xiang, Juanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487815/ https://www.ncbi.nlm.nih.gov/pubmed/34520129 http://dx.doi.org/10.1111/1759-7714.14147 |
Ejemplares similares
-
Chromatin accessibility regulates chemotherapy-induced dormancy and reactivation
por: Wang, Lujuan, et al.
Publicado: (2021) -
Cell-cell contact-driven EphB1 cis- and trans- signalings regulate cancer stem cells enrichment after chemotherapy
por: Wang, Lujuan, et al.
Publicado: (2022) -
Exosomes from cisplatin-induced dormant cancer cells facilitate the formation of premetastatic niche in bone marrow through activating glycolysis of BMSCs
por: Xu, Jiaqi, et al.
Publicado: (2022) -
Lung microbiome alterations in NSCLC patients
por: Zheng, Leliang, et al.
Publicado: (2021) -
Microbiome Related Cytotoxically Active CD8+ TIL Are Inversely Associated With Lung Cancer Development
por: Zheng, Leliang, et al.
Publicado: (2020)